Olav Hellebø

Olav Hellebø is the founder of Palma Biotech S.L.
Current roles include Chief Executive Officer at Exonate Ltd. starting in 2026, Chairman at Barcelona Bioscience, Director at Oncoinvent ASA since 2025, Director at ReNeuron Ltd. since 2014, Non-Executive Director at Antev Ltd. since 2021, Director at ReNeuron (UK) Ltd. since 2016, and Director at Cytovation AS since 2023.
Former roles include Chief Executive Officer & Executive Director at ReNeuron Group Plc from 2014 to 2022, Chief Executive Officer & Head-Investor Relations at Weifa ASA from 2010 to 2013, Chief Executive Officer at Oncoinvent ASA, Independent Non-Executive Director at Calliditas Therapeutics AB from 2014 to 2019, Head-Biotech Oncology Business Unit at Schering-Plough Corp., Chief Operating Officer at Novartis UK Ltd. from 2003 to 2004, and President-Immunology Operations & SVP at UCB Pharma AS.
Education includes undergraduate studies at Hofstra University and an MBA from Instituto de Estudios Superiores de la Empresa.